Seong Jin Yu

Selective Publications

  1. Zhang Y, Yu S, Tuazon JP, Lee JY, Corey S, Kvederis L, Kingsbury C, Kaneko Y, Borlongan CV, Neuroprotective effects of human bone marrow mesenchymal stem cells against cerebral ischemia are mediated in part by an anti-apoptotic mechanism. Neural Regen Res. 2019; 14(4):597-604
  2. Chen S, Yu SJ, Li Y, Lecca D, Glotfelty E, Choi HI, Hoffer BJ, Greig NH, Kim DS, Wang Y, Post-treatment with PT302, a Long-acting Exendin-4 Sustained Release Formulation, Reduces Neurodegeneration of Dopaminergic Neurons in a 6-Hydroxydopamine Rat Model of Parkinson’s DiseaseSci Rep.2018; 8(1):10722. 
  3. Wu KJ, Yu SJ, Chiang CW, Lee YW, Yen BL, Tseng PC, Kuo LW, Wang Y, Neuroprotective action of human Wharton’s Jelly derived-mesenchymal stromal cell transplants in a rodent model of stroke, Cell Transplant. 2018; 27(1): 096368971880275 [Epub ahead of print]
  4. Wu KJ, Yu SJ, Chiang CW, Lee YW, Yen BL, Hsu CS, Kuo LW, Wang Y. Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury. Brain Circ. 2018; 4(3):124-127.
  5. Wu KJ, Yu SJ, Lee JY, Hoffer B, Wang Y. Improving neurorepair in stroke brain through endogenous neurogenesis-enhancing drugs.Cell Transplant. 2017;26(9):1596-1600. 
  6. Dewan SN, Wang Y, Yu SJ*. Drug treatments that optimize endogenous neurogenesis as a therapeutic option for stroke. Brain Circulation. 2017;3(3):152-155. 
  7. Yu SJ, Airavaara M, Wu KJ, Harvey BK, Liu HS, Yang Y, Zacharek A, Chen J, Wang Y. 9-cis retinoic acid induces neurorepair in stroke brain. Sci Rep. 2017; 7(1):4512.
  8. Wu K, Yu SJ, Shia K, Wu C, Song J, Kuan H, Yeh K, Chen C, Bae E, Wang Y. A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain. Cell Transplant. 2017;26(4):571-583. 
  9. Li Y, Wu KJ, Yu SJ, Tamargo IA, Wang Y, Greig NH. Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke. Exp Neurol. 2017; 288:104-113. 
  10. Tamargo IA, Bader M, Li Y, Yu SJ, Wang Y, Talbot K, DiMarchi RD, Pick CG, Greig NH. Novel GLP-1R/GIPR co-agonist “twincretin” is neuroprotective in cell and rodent models of mild traumatic brain injury. Exp Neurol. 2017; 288:176-186. 
  11. Yu SJ, Wu KJ, Bae EK, Hsu MJ, Richie CT, Harvey BK, Wang Y. Methamphetamine induces a rapid increase of intracellular Ca(++) levels in neurons overexpressing GCaMP5. Addict Biol. 2016;21:255-266. 
  12. Kuo CC, Shen H, Harvey BK, Yu SJ, Kopajtic T, Hinkle JJ, Kyrkanides S, Katz JL, Wang Y. Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area. Psychopharmacology (Berl). 2016 Feb;233(4):661-72. 
  13. Yu SJ, Reiner D, Shen H, Wu KJ, Liu QR, Wang Y. Time-Dependent Protection of CB2 Receptor Agonist in Stroke. PLoS One. 2015;10(7): e0132487 
  14. Wu KJ, Yu SJ, Chiang CW, Cho KH, Lee YW, Yen BL, Kuo LW, Wang Y. Transplantation of human placenta-derived multipotent stem cells reduces ischemic brain injury in adult rats. Cell Transplant. 2015; 24:459-470.
  15. Reiner DJ, Yu SJ, Shen H, He Y, Bae EK, Wang Y. 9‐Cis retinoic acid protects against Methamphetamine‐induced neurotoxicity in nigrostriatal dopamine neurons. Neurotox Res. 2014; 25:248‐261. 

Last Update: 2019-05-03

 505 total views,  4 views today

Comments are closed.